EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancing dermatology with skin equivalents and organoids in pathophysiology and drug testing

Bahar Lakeh, Abbas Shafiee

Acta Biomaterialia · 2025-11 · 207 · 120-130

DOI: 10.1016/j.actbio.2025.10.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Biomaterialia, 2025-11. Verfasst von Bahar Lakeh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Georgetown University School of Medicine, WA, D.C., USA. Hauptthemen laut MEDLINE: Organoids, Skin, Induced Pluripotent Stem Cells, Dermatology. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The progression of dermatologic models from simple two-dimensional cultures to advanced three-dimensional skin equivalents (SE) and skin organoids (SKO) has transformed skin research and therapy. This scoping review explores the evolution of SE, with a particular emphasis on human-induced pluripotent stem cells (hiPSCs)-derived SKO, and skin-on-chip as next-generation bioengineered platforms for disease modelling and drug discovery. We present a critical synthesis of current evidence on the development and applications of these models for recapitulating skin pathophysiology, testing therapeutic strategies, and identifying limitations of existing systems, thereby offering an evidence-based overview of existing knowledge in dermatology. This review highlights the application of such skin models across diverse fields, including aging, inflammatory and infectious diseases, radiation biology, pharmacology, and hair research. Together, recent advancements, including the incorporation of skin appendages, vascular, immune, and neural components into increasingly complex in vitro models, represent a path forward to enhance clinical relevance in dermatological research and therapy while simultaneously reducing reliance on animal models. STATEMENT OF SIGNIFICANCE: This study offers a comprehensive and timely analysis of the evolution of skin experimental models, such as skin equivalents and organoids, and their applications in dermatology. It helps dermatology researchers to assess the current limitation of skin models and identify future directions in skin model development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsSkinInduced Pluripotent Stem CellsDermatologyHumansAnimalsDrug Evaluation, PreclinicalModels, Biological

Stichwörter der Autor:innen

AgingAtopic dermatitisHairIchthyosisInduced pluripotent stem cellsInfectious diseaseInflammatory diseasePsorasisRadiationRegenerationSkin organoidSkin-on-chipTissue engineering

Autor:innen und Institutionen

  • Georgetown University School of Medicine, WA, D.C., USA.
  • Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD 4102, Australia; Metro North Hospital and Health Service, Queensland Health, Brisbane, QLD 4029, Austra…

Zitieren

APA

Lakeh, B., & Shafiee, A. (2025). Advancing dermatology with skin equivalents and organoids in pathophysiology and drug testing. Acta Biomaterialia, 207, 120-130. https://doi.org/10.1016/j.actbio.2025.10.008

Vancouver

Lakeh B, Shafiee A. Advancing dermatology with skin equivalents and organoids in pathophysiology and drug testing. Acta Biomaterialia. 2025;207:120-130. doi:10.1016/j.actbio.2025.10.008

BibTeX
@article{Lakeh2025,
  author = {Lakeh, Bahar and Shafiee, Abbas},
  title = {Advancing dermatology with skin equivalents and organoids in pathophysiology and drug testing},
  journal = {Acta Biomaterialia},
  year = {2025},
  volume = {207},
  pages = {120--130},
  doi = {10.1016/j.actbio.2025.10.008}
}
Kostenlos starten →